JRCT ID: jRCT1030230180
Registered date:25/06/2023
Validation of the reduced morningness-eveningness questionnaire (rMEQ: reduced morningness-eveningness questionnaire) in Japanese
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | Circadian rhythm disorders |
Date of first enrollment | 25/06/2023 |
Target sample size | 2243 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | In Study 2, the subjects spend 6 hours in a dark (less than 1 lx illumination) laboratory and saliva is collected once an hour. |
Outcome(s)
Primary Outcome | Association between chronotypes determined by MEQ and rMEQ, respectively Association between DLMO and sleep rhythm phase and chronotypes determined by rMEQ |
---|---|
Secondary Outcome | Questionnaires with significant contribution to chronotype determination Association of chronotype with sleep irregularities |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | <= 79age old |
Gender | Both |
Include criteria | Study 1: 1) Persons who are between 20 and 79 years old at the time of response. 2) Who are able to respond to the questionnaire via the Internet. Study 2 1) Males and females between 20 and 60 years of age at the time of consent |
Exclude criteria | Study 1:. 1) Persons with pre-existing medical conditions (cardiovascular, liver, endocrine system, brain/neurological, psychiatric, etc.), taking therapeutic drugs, or having a history of such conditions that may affect the study results 2) Persons who are dependent on alcohol or who are found to be in the habit of excessive alcohol consumption 3) Those who have a habit of taking drugs or supplements that affect sleep. 4) Pregnant, lactating, or planning to become pregnant during the study period 5) Who are using an implantable medical device such as a pacemaker 6) Any other person deemed inappropriate by the principal investigator. Study 2: The following are not included in the study 1) Persons with pre-existing medical conditions (cardiovascular, liver, endocrine, brain/neurological, psychiatric, etc.), taking therapeutic drugs, or having a history of such conditions that may affect the results of the study 2) Those who have engaged in time-lagged travel or shift work at least 6 months prior to the experiment. 3) Persons who have been found to be dependent on alcohol or to have excessive drinking habits 4) Persons with excessive smoking habits 5) Those who have a habit of taking drugs or supplements that affect sleep 6) Those with abnormal color vision 7) Those who have a phobia of dark places 8) Other subjects deemed inappropriate by the principal investigator |
Related Information
Primary Sponsor | Kitamura Shingo |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Japan Society for the Promotion of Science |
Secondary ID(s) |
Contact
Public contact | |
Name | Eto Taisuke |
Address | 4-1-1 Ogawa-Higashi, Kodaira, Tokyo Tokyo Japan 187-8551 |
Telephone | +81-42-346-2071 |
eto@ncnp.go.jp | |
Affiliation | National Center of Neurology and Psychiatry |
Scientific contact | |
Name | Shingo Kitamura |
Address | 4-1-1 Ogawa-Higashi, Kodaira, Tokyo Tokyo Japan 187-8551 |
Telephone | +81-42-346-2071 |
s-kita@ncnp.go.jp | |
Affiliation | National Center of Neurology and Psychiatry |